Jeffrey P. Jacobs, MD, FACS, FACC, FCCP, will present an abstract on the Variation in Survival Over Time in Patients with COVID-19 Supported with ECMO: A Multi-institutional analysis of 471 consecutive COVID-19 patients supported with ECMO across 55 centers in 21 States at this year’s American Association for Thoracic Surgery (AATS) Conference.
About Jeffrey P. Jacobs, MD, FACS, FACC, FCCP
Jeffrey P. Jacobs is a Professor of Surgery in Pediatrics in the Congenital Heart Center at the University of Florida and UF Health Shands Children’s Hospital. He previously served multiple roles at John Hopkins, including cardiac surgeon at John Hopkins All Children’s Hospital and Professor of Surgery and Pediatrics at Johns Hopkins University.
He performs pediatric and adult congenital cardiothoracic surgery and has performed over 4,200 operations. Other notable positions held include the Director of the Johns Hopkins All Children’s Hospital Heart Transplantation Program, Director of the Andrews/Daicoff Cardiovascular Program at Johns Hopkins All Children’s Hospital, and Chief of Cardiovascular Surgery.
Jacobs is also Editor of Chief of Cardiology in the Young, a widely read journal dedicated to patients with pediatric and congenital heart cardiac diseases, and Co-Chair of the 2023 World Congress of Pediatric Cardiology and Cardiac Surgery.
This multi-institutional analysis studied the survival rate in COVID-19 patients supported with ECMO. This study examined patient characteristics, treatments, and outcome variations throughout the pandemic.
The study used a multi-institutional database of COVID-19 patients supported with and separated from ECMO between March 2020 and October 2021. The analysis concluded that “Survival for patients with COVID-19 supported with ECMO has improved following the time-dependent reduction in survival seen during the middle stages of the pandemic. Our multi-institutional analysis of 471 consecutive COVID-19 patients who were supported with ECMO and subsequently decannulated provides clear evidence that ECMO facilitates salvage and survival of select critically ill patients with COVID-19.”
The American Association for Thoracic Surgery (AATS) was founded in 1817 to advance the cardiothoracic surgery field. This international organization has set itself apart in the specialty, and its members have made notable contributions to the care and treatment of cardiothoracic disease.
AATS 2022 will run from May 13-17 in Boston, bringing together cardiothoracic pioneers and future leaders. Conference attendees will get to engage with influencers, decision-makers, and team members who are building the future of adult cardiac, thoracic, congenital, and perioperative specialties.
This year’s conference will include two exhibit halls. The Aortic and Mitral Exhibit Hall will take place on Friday and Saturday morning. The main Exhibit Hall will open on Saturday evening, where the welcome reception will occur. This hall will remain open through Monday, May 16.
ECMO Services and Support
SpecialtyCare is an industry leader in perfusion services and a trusted partner. Our expertise in setting up an efficient, cost-effective, adequately staffed OR with top-of-the-line equipment helps us offer advice on establishing an ECMO program or evaluating your current one. Contact us today if you’re interested in how SpecialtyCare can help build your hospital’s ECMO program.
SpecialtyCare is dedicated to providing an exceptional patient experience, becoming the OR employer of choice, and leading the way in OR innovation.